Ryzolt Dosage

Your healthcare provider will recommend a starting dose of Ryzolt based on several factors, such as the severity of your pain, other medications you are taking, and other medical conditions you may have. If you are not switching from a short-acting tramadol, the recommended starting dosage is 100 mg once daily. Your healthcare provider may then slowly increase your dosage up to a maximum of 300 mg total per day.

Dosage of Ryzolt: An Introduction

The Ryzolt (tramadol ER) dose that your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • The type and dose of other painkillers you have taken
  • The severity of your pain
  • How you respond to Ryzolt
  • Other medications you are taking
  • Other medical conditions you may have.
     
As is always the case, do not adjust your dosage unless your healthcare provider specifically instructs you to do so.
 

Ryzolt Dosing for Pain

For people who are not switching from short-acting tramadol, the recommended starting Ryzolt dosage is 100 mg once daily. Your healthcare provider may slowly increase your dose as necessary (by 100 mg every five days), until a maximum of 300 mg daily is reached.
 
If you are switching to Ryzolt from short-acting tramadol, your healthcare provider will calculate your Ryzolt dosage based on your current tramadol dosage. The total amount of tramadol you currently take per day will be calculated and rounded down to the nearest 100 mg strength. For instance, if you take a total of 250 mg of tramadol per 24 hours, your starting dose of Ryzolt will be 200 mg once daily. The maximum dosage of Ryzolt is 300 mg once daily.
 
If you are over 65 years old, your healthcare provider should start with a low Ryzolt dosage and increase your dose with caution. If you are over 75 years old, Ryzolt should be used only with great caution, due to the increased risk of side effects in older individuals.
 
(Ryzolt Dosage Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation